STUDIES ON THE INTERACTION BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND VITRONECTIN

被引:13
|
作者
SIGURDARDOTTIR, O [1 ]
WIMAN, B [1 ]
机构
[1] KAROLINSKA HOSP,DEPT CLIN CHEM,S-10401 STOCKHOLM 60,SWEDEN
关键词
D O I
10.1016/0268-9499(92)90044-I
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, the functionally active form of plasminogen activator inhibitor type-1 (PAI-1) was found to bind to vitronectin both in plasma and in extracellular matrix. In the present study the formation of the complex between functionally active PAI-1 and vitronectin has been studied using vitronectin-coated microtitre plates. PAI-1 bound to vitronectin in the microtitre plates was quantified using HRP-conjugated monoclonal antibodies towards PAI-1. Even at PAI-1 concentrations of about 1 pmol/l the binding to the vitronectin-coated plates seem to be quantitative suggesting high affinity. In contrast, with 'latent' PAI-1 at similar molar concentrations, no binding was observed. The effects of pH, NaCl, KBr, KSCN, urea, guanidinium chloride and certain amino acids were studied on the interaction between active PAI-1 and vitronectin. The interaction was not affected at a wide pH range or by increasing the ionic strength by addition of NaCl, suggesting that the binding is more complicated than just an ionic binding. In addition, no effect was observed on the complex formation by 2 mol/l KBr. In contrast, 0.5 mol/l KSCN almost completely abolished complex formation. Furthermore, arginine and guanidinium chloride, both dissociated the complex readily. Half maximal binding was obtained at about 0.3 mol/l for both substances. In contrast hardly any effect was obtained with epsilon aminocaproic acid (EACA) or lysine in concentrations up to 1.6 mol/l. Our results suggest that guanidine groups and most likely also hydrophobic interactions are involved in the binding of the active form of PAI-1 to vitronectin.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 50 条
  • [31] ITO CELLS SYNTHESIZE PLASMINOGEN-ACTIVATOR INHIBITOR-1 - REGULATION BY CORTICOSTEROIDS AND PLASMINOGEN-ACTIVATOR
    KNITTEL, T
    FELLMER, P
    RAMADORI, G
    GASTROENTEROLOGY, 1995, 108 (04) : A1100 - A1100
  • [32] STRUCTURAL REQUIREMENTS FOR THE EXTRACELLULAR INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 WITH ENDOTHELIAL-CELL MATRIX-ASSOCIATED VITRONECTIN
    PREISSNER, KT
    GRULICHHENN, J
    EHRLICH, HJ
    DECLERCK, P
    JUSTUS, C
    COLLEN, D
    PANNEKOEK, H
    MULLERBERGHAUS, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (30) : 18490 - 18498
  • [33] PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS THE PRIMARY INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PREGNANCY PLASMA
    JORGENSEN, M
    PHILIPS, M
    THORSEN, S
    SELMER, J
    ZEUTHEN, J
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (03) : 872 - 878
  • [34] Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin
    Luo, M.
    Ji, Y.
    Luo, Y.
    Li, R.
    Fay, W. P.
    Wu, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (12) : 2451 - 2460
  • [35] KINETIC-ANALYSIS OF THE INTERACTIONS BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND BOTH UROKINASE AND TISSUE PLASMINOGEN-ACTIVATOR
    HEKMAN, CM
    LOSKUTOFF, DJ
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 262 (01) : 199 - 210
  • [36] IDENTIFICATION OF THE VITRONECTIN BINDING DOMAIN IN PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) BY RANDOM MUTAGENESIS
    LAWRENCE, DA
    BERKENPAS, MB
    PALANIAPPAN, S
    GINSBURG, D
    BLOOD, 1993, 82 (10) : A451 - A451
  • [37] PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BY COMPLICATIONS
    SUMINSKI, R
    DASILVA, S
    SMITH, M
    ERBEY, J
    DIABETES, 1994, 43 : A197 - A197
  • [38] AMINO-ACID-RESIDUES THAT AFFECT INTERACTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR WITH PLASMINOGEN-ACTIVATOR INHIBITOR-1
    MADISON, EL
    GOLDSMITH, EJ
    GERARD, RD
    GETHING, MJH
    SAMBROOK, JF
    BASSELDUBY, RS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) : 3530 - 3533
  • [39] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 LOCUS IS ASSOCIATED WITH ALTERED LEVELS OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY
    DAWSON, S
    HAMSTEN, A
    WIMAN, B
    HENNEY, A
    HUMPHRIES, S
    ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 183 - 190
  • [40] FLUORESCENCE STUDIES OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (RPAI-1)
    VAUGHAN, DE
    ESTELLA, P
    DECLERCK, PJ
    COLLEN, D
    CIRCULATION, 1990, 82 (04) : 305 - 305